Prognostic score for life expectancy evaluation of lung cancer patients after bone metastasis

Abstract

Background This study identifies the overall survival status of lung cancer patients with bone metastasis and metastasis patterns. Poor prognostic factors were identified to develop a scoring system for estimating survival period after bone metastasis. Methods A retrospective cohort analysis was performed at Chiang Mai University for the period January 1, 2006 and December 31, 2013. Time-to-event analysis was performed to estimate survival rate. The primary end point was death related to lung cancer. Univariate and multivariate analysis of the prognostic variables was done using the Cox's regression model. The score was derived from the corresponding estimated regression coefficients of significantly poor prognostic factors. Results A total of 505 lung cancer with bone metastasis patients were analyzed. Four hundred two cases (79.6%) were concurrent diagnosis and 103 (20.4%) were subsequent diagnosis. The median survival time of lung cancer after bone metastasis 148 days. Male gender and ECOG 3–4 were significant poor prognostic factors for lung cancer after bone metastasis, with hazard ratios of 1.42 (95% CI 1.17–1.73), and 1.30 (95% CI 1.06–1.60), respectively. Prognosis score was determined using the binary term present/not-present for those factors. The curve from prognostic score summations of 2, 1 and 0 presented a good discrimination of survival expectancy, showing an expected median survival time of approximately 109, 146, and 225 days, respectively. Conclusions Prognostic score is a clinically simple and easy method for estimating life expectancy and for guiding interventions in bone metastasis of lung cancer.

An Artificial Intelligence Model for Predicting 1-Year Survival of Bone Metastases in Non-Small-Cell Lung Cancer Patients Based on XGBoost Algorithm

“…T stage roughly classifies tumor size or depth of invasion, but it cannot reflect the specific character of NSCLC patients with BM and accurately predict the prognosis, because the tumor size of the same period varies greatly [ 23 – 25 ]. Age, tumor size, race, sex, histological types, grade, T stage, N stage, surgery, chemotherapy, liver metastases, and radiotherapy were related to prognosis, which was similar to the previous research [ 26 – 30 ]. The presence of liver metastases significantly decreased survival in lung cancer patients with BM [ 17 ].…”

A Diagnostic Scoring System to Distinguish Precocious Puberty from Premature Thelarche based on Clinical and Laboratory Findings

“…We compared with other diagnostic or prognostic scoring models regarding it diagnostic value. There are many clinical scoring models (35,36). Compared with previous scoring models, such as scoring system to distinguish uncomplicated from complicated acute appendicitis, our models have similar diagnostic value (37).…”

Metastatic Prostate Carcinoma from Imperial Rome (1st to 2nd Centuries AD)

“…Small cell lung cancer can produce osteoblastic or mixed lesions, affecting mostly the spine, ribs, and pelvis, in patients treated with chemotherapy that allows a longer survival time, as reported in the clinical literature [42]. In the Casal Bertone skeleton the lung metastases are unlikely to have spread in such a massive and disseminated manner in almost all of the bones, since lung cancer has a very short-term prognosis in the absence of therapy [41,43]. Periosteal reactions are highly unusual in metastatic cancer, except in prostate, breast and gastrointestinal tumors, but the latter rarely produce bone metastases [41].…”